微生态疗法抗新型冠状病毒肺炎研究进展  

Microecological therapy against coronavirus disease 2019: research progress

作　　者：蔡贺南 丁向萍[1] 王承建[1] 黄晓浪 傅思武[1] CAI He-nan;DING Xiang-ping;WANG Cheng-jian;HUANG Xiao-lang;FU Si-wu(Medical College,Northwest Minzu University,Lanzhou,Gansu 730030,China)

机构地区：[1]西北民族大学医学部,甘肃兰州730030 [2]西安医学高等专科学校临床医学院

出　　处：《中国微生态学杂志》2022年第11期1356-1359,1364,共5页Chinese Journal of Microecology

基　　金：西北民族大学中央高校重点项目(31920180096)。

摘　　要：2019年底湖北省武汉市出现新型冠状病毒肺炎(coronavirus disease 2019,COVID-19)疫情,传染性强,传播速度快,流行范围广,引起国内外学者高度关注。该病作为急性呼吸道传染病已纳入《中华人民共和国传染病防治法》规定的乙类传染病,按甲类传染病管理。WHO宣布将COVID-19疫情列为国际关注的突发公共卫生事件。目前针对新型冠状病毒(SARS-CoV-2)感染的临床治疗主要以改善症状为主,尚缺少直接针对SARS-CoV-2的特效药。本文通过文献检索就COVID-19现有主要治疗方法和微生态疗法相关研究进行综述,以期为微生态辅助治疗提供参考。Coronavirus disease 2019(COVID-19) pandemic that began to spread in Wuhan, Hubei province at the end of2019 is highly contagious, which spreads and expanded rapidly, and has attracted great attention from scholars at home and abroad. As an acute respiratory infectious disease, it has been included in the Class B infectious diseases stipulated in the Law of the People’s Republic of China on the Prevention and Control of Infectious Diseases, and is managed as a Class A infectious disease. The WHO announced the COVID-19 outbreak a public health emergency of international concern. At present, the clinical treatment of SARS-CoV-2 infection is mainly to improve symptoms, and there is still a lack of specific drugs against SARS-CoV-2. This paper reviews the main existing treatment methods of COVID-19 and related research on microecological therapy through literature search, in order to provide a reference for micro-ecological adjuvant therapy.

关 键 词：微生态疗法 新型冠状病毒肺炎 呼吸道传染病 微生态制剂 

分 类 号：R511[医药卫生—内科学] R563.1[医药卫生—临床医学]